Trial NCT05770531

View at ClinicalTrials.gov 
Org. Study IDs: VICCBRE2257
Secondary IDs: NCI-2023-01721

Last trial update was posted on 2024-03-27

MeSH Interventions

Sacituzumab govitecan

MeSH Conditions

Breast Neoplasms Carcinoma

Other Conditions

Metastatic HER2-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma

Stopping Reasons

Pending calendar changes

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID